Advanced
  Home Compare Reports

Comparison with Similar Reports

In Vitro Diagnostics (IVD) Quality Control Market, by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Molecula...

Publisher:        MarketsandMarkets

# of Pages:        333

Rating: 

1 User License $4,950

Publication Date:  September, 2021

Price:       $4,950 / User License




1 INTRODUCTION 36
1.1 OBJECTIVES OF THE STUDY 36
1.2 MARKET DEFINITION 36
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 37
1.3 MARKET SCOPE 37
1.3.1 MARKETS COVERED 37
1.3.2 YEARS CONSIDERED FOR THE STUDY 38
1.3.3 CURRENCY 38
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 38
1.4 STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
FIGURE 1 RESEARCH DESIGN 41
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 43
FIGURE 2 PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 44
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND- SIDE PARTICIPANTS 45
2.2 MARKET SIZE ESTIMATION 46
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 46
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BIO-RAD LABORATORIES, INC. 47
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: IVD QUALITY CONTROL MARKET (2020) 47
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE IVD QUALITY CONTROL MARKET (2021–2026) 49
FIGURE 9 CAGR PROJECTIONS 49
FIGURE 10 TOP-DOWN APPROACH 50
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 51
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 51
2.4 MARKET SHARE ANALYSIS 51
2.5 ASSUMPTIONS FOR THE STUDY 52
2.6 RISK ASSESSMENT 53
TABLE 2 RISK ASSESSMENT: IVD QUALITY CONTROL MARKET 53
2.7 LIMITATIONS 53
2.7.1 METHODOLOGY-RELATED LIMITATIONS 53
2.7.2 SCOPE-RELATED LIMITATIONS 53
3 EXECUTIVE SUMMARY 54
FIGURE 12 IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 54
FIGURE 13 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 55
FIGURE 14 IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2021 VS. 2026 (USD MILLION) 55
FIGURE 15 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 56
FIGURE 16 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 56
FIGURE 17 IVD QUALITY CONTROL MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 57
FIGURE 18 IVD QUALITY CONTROL MARKET: GEOGRAPHIC SNAPSHOT 58
4 PREMIUM INSIGHTS 59
4.1 IVD QUALITY CONTROL MARKET OVERVIEW 59
FIGURE 19 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET GROWTH 59
4.2 APAC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY AND COUNTRY (2020) 60
FIGURE 20 IMMUNOCHEMISTRY TO COMMAND THE LARGEST SHARE OF THE APAC IVD QUALITY CONTROL MARKET IN 2020 60
4.3 IVD QUALITY CONTROL MARKET: GEOGRAPHIC MIX 61
FIGURE 21 CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 61
4.4 IVD QUALITY CONTROL MARKET: DEVELOPED VS DEVELOPING MARKETS 61
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHEST CAGR DURING THE FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 MARKET DYNAMICS 62
FIGURE 23 IVD QUALITY CONTROL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
5.1.1 MARKET DRIVERS 63
5.1.1.1 Increasing number of accredited clinical laboratories 63
FIGURE 24 US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION,
BY ORGANIZATION (2018) 63
5.1.1.2 Growing adoption of third-party quality controls 64
5.1.1.3 Rising demand for external quality assessment support 64
5.1.1.4 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases 65
TABLE 3 ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION
(2019–2050) 65
FIGURE 25 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040 66
FIGURE 26 GLOBAL CANCER INCIDENCE, 2015–2040 66
5.1.1.5 Increasing adoption of POC instruments in developed regions 67
TABLE 4 MARKET DRIVERS: IMPACT ANALYSIS 67
5.1.2 MARKET RESTRAINTS 67
5.1.2.1 Additional costs and budget constraints in hospitals and laboratories 67
5.1.2.2 Unfavorable reimbursement scenario for IVD tests 68
TABLE 5 MARKET RESTRAINTS: IMPACT ANALYSIS 68
5.1.3 MARKET OPPORTUNITIES 68
5.1.3.1 Rising demand for multi-analyte controls 68
TABLE 6 MARKET OPPORTUNITIES: IMPACT ANALYSIS 69
5.1.4 MARKET CHALLENGES 69
5.1.4.1 Stringent product approval process 69
5.1.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries 69
TABLE 7 MARKET CHALLENGES: IMPACT ANALYSIS 69
5.2 INDUSTRY TRENDS 70
5.2.1 LYOPHILIZED/FREEZE-DRIED CONTROLS 70
TABLE 8 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED
BY KEY MARKET PLAYERS 70
5.2.2 TRENDS ON ANALYTE SOURCE: HUMAN VS. ANIMAL ORIGIN 70
5.2.3 CONSOLIDATION OF LABORATORIES 71
5.3 VALUE CHAIN ANALYSIS 71
FIGURE 27 IVD QUALITY CONTROL MARKET: VALUE CHAIN ANALYSIS 71
5.4 SUPPLY CHAIN ANALYSIS 72
FIGURE 28 IVD QUALITY CONTROL MARKET: SUPPLY CHAIN ANALYSIS 73
5.5 ECOSYSTEM MARKET MAP 73
FIGURE 29 IVD QUALITY CONTROL MARKET: ECOSYSTEM MARKET MAP 74
5.6 PORTER’S FIVE FORCES ANALYSIS 74
5.6.1 THREAT FROM NEW ENTRANTS 74
5.6.2 THREAT FROM SUBSTITUTES 75
5.6.3 BARGAINING POWER OF SUPPLIERS 75
5.6.4 BARGAINING POWER OF BUYERS 75
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 76
5.7 REGULATORY ANALYSIS 76
5.7.1 NORTH AMERICA 76
5.7.1.1 US 76
TABLE 9 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL 77
TABLE 10 US: TIME, COST, AND COMPLEXITY OF REGISTRATION 77
5.7.1.2 Canada 78
TABLE 11 CANADA: CLASSIFICATION OF IVD PRODUCTS 78
TABLE 12 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 78
5.7.2 EUROPE 78
TABLE 13 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES 79
TABLE 14 EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION 79
5.7.3 ASIA PACIFIC 80
5.7.3.1 Japan 80
TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 80
5.7.3.2 China 81
TABLE 16 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 81
5.7.3.3 India 81
TABLE 17 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION 82
5.8 IMPACT OF COVID-19 ON THE IVD QUALITY CONTROL MARKET 82
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 83
FIGURE 31 ROCHE DIAGNOSTICS.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 83
FIGURE 32 BIO-RAD LABORATORIES, INC.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 84
FIGURE 33 ABBOTT LABORATORIES: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 84
5.9 PATENT ANALYSIS 85
5.9.1 PATENT PUBLICATION TRENDS FOR IVD QUALITY CONTROLS 85
FIGURE 34 PATENT PUBLICATION TRENDS (2011–AUGUST 2021) 85
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 86
FIGURE 35 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR IVD QUALITY CONTROL PATENTS (JANUARY 2011–AUGUST 2021) 86
FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR IVD QUALITY CONTROL PATENTS (JANUARY 2011–AUGUST 2021) 87
5.10 TECHNOLOGY ANALYSIS 87
5.10.1 KEY TECHNOLOGIES 88
5.10.1.1 Analyte extraction 88
5.10.1.1.1 Specimen pooling 88
5.10.1.1.2 Human monoclonals 88
5.10.1.2 Specimen processing 88
5.10.1.2.1 Inactivation 88
5.10.1.2.2 Dilution 89
5.10.1.3 Preservation 89
5.10.2 ADJACENT TECHNOLOGIES 89
5.10.2.1 Sensor-based quality control 89
5.10.3 COMPLEMENTARY TECHNOLOGIES 89
5.10.3.1 Storage 89
5.10.3.2 Transport 90
5.10.3.3 Temperature control 90
5.10.3.4 Temperature monitoring 90
 
6 IVD QUALITY CONTROL MARKET, BY PRODUCT AND SERVICE 91
6.1 INTRODUCTION 92
TABLE 18 IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 92
6.2 QUALITY CONTROL PRODUCTS 92
TABLE 19 QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 20 QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 93
6.2.1 SERUM/PLASMA-BASED CONTROLS 94
6.2.1.1 Greater stability and accuracy of diagnostic test results to increase the demand for serum/plasma-based controls 94
TABLE 21 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 94
TABLE 22 SERUM/PLASMA-BASED QUALITY CONTROL PRODUCTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 95
6.2.2 WHOLE BLOOD-BASED CONTROLS 95
6.2.2.1 Rising need to ensure high-quality clinical test results to drive the whole blood-based controls market 95
TABLE 23 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 96
TABLE 24 WHOLE BLOOD-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
6.2.3 URINE-BASED CONTROLS 97
6.2.3.1 The growing incidence of kidney diseases increase the need for urine-based controls 97
TABLE 25 URINE-BASED IVD CONTROLS OFFERED BY KEY MARKET PLAYERS 98
TABLE 26 URINE-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
6.2.4 OTHER CONTROLS 99
TABLE 27 OTHER CONTROLS OFFERED BY KEY MARKET PLAYERS 100
TABLE 28 OTHER QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
6.3 DATA MANAGEMENT SOLUTIONS 101
6.3.1 RISING FOCUS ON IMPROVING THE ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH 101
TABLE 29 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 102
TABLE 30 DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 103
6.4 QUALITY ASSURANCE SERVICES 103
6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE THE DEMAND FOR QUALITY ASSURANCE SERVICES 103
TABLE 31 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS 104
TABLE 32 QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 105
7 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY 106
7.1 INTRODUCTION 107
TABLE 33 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 107
7.2 IMMUNOCHEMISTRY 107
7.2.1 FOCUS ON MONITORING THE PRECISION OF IMMUNOASSAY TESTS TO DRIVE THE ADOPTION OF IMMUNOASSAY CONTROLS 107
TABLE 34 QUALITY CONTROLS FOR IMMUNOCHEMISTRY OFFERED BY KEY MARKET PLAYERS 108
TABLE 35 IVD QUALITY CONTROL MARKET FOR IMMUNOCHEMISTRY, BY COUNTRY, 2019–2026 (USD MILLION) 109
7.3 CLINICAL CHEMISTRY 109
7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH 109
TABLE 36 QUALITY CONTROLS FOR CLINICAL CHEMISTRY OFFERED BY KEY MARKET PLAYERS 110
TABLE 37 IVD QUALITY CONTROL MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2019–2026 (USD MILLION) 111
7.4 MOLECULAR DIAGNOSTICS 111
7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS 111
TABLE 38 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED
BY KEY MARKET PLAYERS 112
TABLE 39 IVD QUALITY CONTROL MARKET FOR MOLECULAR DIAGNOSTICS,
BY COUNTRY, 2019–2026 (USD MILLION) 113
7.5 MICROBIOLOGY 114
7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH 114
TABLE 40 QUALITY CONTROLS FOR MICROBIOLOGY OFFERED BY KEY MARKET PLAYERS 114
TABLE 41 IVD QUALITY CONTROL MARKET FOR MICROBIOLOGY, BY COUNTRY,
2019–2026 (USD MILLION) 115
7.6 HEMATOLOGY 115
7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS 115
TABLE 42 QUALITY CONTROLS FOR HEMATOLOGY OFFERED BY KEY MARKET PLAYERS 116
TABLE 43 IVD QUALITY CONTROL MARKET FOR HEMATOLOGY, BY COUNTRY,
2019–2026 (USD MILLION) 117
7.7 COAGULATION & HEMOSTASIS 117
7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE
THE NEED FOR COAGULATION & HEMOSTASIS TESTING 117
TABLE 44 QUALITY CONTROLS FOR COAGULATION & HEMOSTASIS OFFERED
BY KEY MARKET PLAYERS 118
TABLE 45 IVD QUALITY CONTROL MARKET FOR COAGULATION & HEMOSTASIS,
BY COUNTRY, 2019–2026 (USD MILLION) 119
7.8 OTHER TECHNOLOGIES 120
TABLE 46 QUALITY CONTROLS FOR OTHER TECHNOLOGIES OFFERED BY KEY MARKET PLAYERS 120
TABLE 47 IVD QUALITY CONTROL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION) 121
8 IVD QUALITY CONTROL MARKET, BY MANUFACTURER 122
8.1 INTRODUCTION 123
TABLE 48 IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 123
8.2 THIRD-PARTY CONTROLS 123
TABLE 49 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 50 THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 124
8.2.1 INDEPENDENT CONTROLS 125
8.2.1.1 Increased preference for independent controls to fuel market growth 125
TABLE 51 INDEPENDENT CONTROLS OFFERED BY KEY MARKET PLAYERS 125
TABLE 52 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 126
8.2.2 INSTRUMENT-SPECIFIC CONTROLS 126
8.2.2.1 Usage limitations to subdue market growth rate in favor of independent controls 126
TABLE 53 INSTRUMENT-SPECIFIC CONTROLS OFFERED BY KEY MARKET PLAYERS 127
TABLE 54 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 128
8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS 128
8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES 128
TABLE 55 OEM CONTROLS OFFERED BY KEY MARKET PLAYERS 129
TABLE 56 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130
9 IVD QUALITY CONTROL MARKET, BY END USER 131
9.1 INTRODUCTION 132
TABLE 57 IVD QUALITY CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 132
9.2 HOSPITALS 132
9.2.1 HUGE VOLUME OF IVD PROCEDURES PERFORMED IN HOSPITALS TO DRIVE MARKET GROWTH 132
TABLE 58 IVD QUALITY CONTROL MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 133
9.3 CLINICAL LABORATORIES 133
9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE THE MARKET 133
TABLE 59 IVD QUALITY CONTROL MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 135
9.4 ACADEMIC AND RESEARCH INSTITUTES 135
9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET GROWTH 135
TABLE 60 IVD QUALITY CONTROL MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 136
 
9.5 OTHER END USERS 137
TABLE 61 IVD QUALITY CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 137
10 IVD QUALITY CONTROL MARKET, BY REGION 138
10.1 INTRODUCTION 139
TABLE 62 IVD QUALITY CONTROL MARKET, BY REGION, 2019–2026 (USD MILLION) 139
TABLE 63 IVD QUALITY CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 140
10.2 NORTH AMERICA 140
FIGURE 37 NORTH AMERICA: IVD QUALITY CONTROL MARKET SNAPSHOT 141
TABLE 64 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
TABLE 65 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 142
TABLE 66 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 67 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 142
TABLE 68 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019–2026 (USD MILLION) 143
TABLE 69 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 70 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 143
10.2.1 US 144
10.2.1.1 High healthcare expenditure in the country and the implementation of mandatory laboratory accreditation and quality assurance guidelines in laboratories to drive market growth in the US 144
TABLE 71 US: KEY MACROINDICATORS 144
TABLE 72 US: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 145
TABLE 73 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 74 US: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 145
TABLE 75 US: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 146
TABLE 76 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 77 US: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 146
10.2.2 CANADA 147
10.2.2.1 Government initiatives to promote quality controls to drive market growth in Canada 147
TABLE 78 CANADA: KEY MACROINDICATORS 147
TABLE 79 CANADA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 148
TABLE 80 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 81 CANADA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 148
TABLE 82 CANADA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 149
TABLE 83 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 84 CANADA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 149
10.3 EUROPE 150
TABLE 85 EUROPE: IVD QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 150
TABLE 86 EUROPE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 151
TABLE 87 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 88 EUROPE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 151
TABLE 89 EUROPE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 152
TABLE 90 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 91 EUROPE: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 152
10.3.1 GERMANY 153
10.3.1.1 Increasing number of certified laboratories and the rising volume of high-quality tests performed by these laboratories to support market growth in Germany 153
TABLE 92 GERMANY: KEY MACROINDICATORS 153
TABLE 93 GERMANY: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 153
TABLE 94 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 95 GERMANY: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 154
TABLE 96 GERMANY: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 154
TABLE 97 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 98 GERMANY: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 155
10.3.2 FRANCE 155
10.3.2.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market growth 155
TABLE 99 FRANCE: KEY MACROINDICATORS 156
TABLE 100 FRANCE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 156
TABLE 101 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 102 FRANCE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 157
TABLE 103 FRANCE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 157
TABLE 104 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 105 FRANCE: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 158
10.3.3 UK 158
10.3.3.1 Growth in the life science industry and increased research to drive market growth in the UK 158
TABLE 106 UK: KEY MACROINDICATORS 159
TABLE 107 UK: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 159
TABLE 108 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 109 UK: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 160
TABLE 110 UK: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 160
TABLE 111 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 112 UK: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 161
10.3.4 ITALY 161
10.3.4.1 Growing disease prevalence to drive the demand for better and more accurate disease diagnosis in Italy 161
TABLE 113 ITALY: KEY MACROINDICATORS 162
TABLE 114 ITALY: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 162
TABLE 115 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 116 ITALY: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 163
TABLE 117 ITALY: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 163
TABLE 118 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 119 ITALY: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 164
10.3.5 SPAIN 164
10.3.5.1 Increasing demand for prenatal and genetic testing and rising focus on laboratory consolidation to support market growth in Spain 164
TABLE 120 SPAIN: KEY MACROINDICATORS 164
TABLE 121 SPAIN: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 165
TABLE 122 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 123 SPAIN: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 165
TABLE 124 SPAIN: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 166
TABLE 125 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 126 SPAIN: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 166
10.3.6 RUSSIA 167
10.3.6.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market growth in Russia 167
TABLE 127 RUSSIA: KEY MACRO INDICATORS 167
TABLE 128 RUSSIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 167
TABLE 129 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 130 RUSSIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 168
TABLE 131 RUSSIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 168
TABLE 132 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 133 RUSSIA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 169
10.3.7 REST OF EUROPE 169
TABLE 134 ROE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 170
TABLE 135 ROE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 136 ROE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 170
TABLE 137 ROE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 171
TABLE 138 ROE: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 139 ROE: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 171
10.4 ASIA PACIFIC 172
FIGURE 38 ASIA PACIFIC: IVD QUALITY CONTROL MARKET SNAPSHOT 173
TABLE 140 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 174
TABLE 141 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 174
TABLE 142 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 143 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 175
TABLE 144 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 175
TABLE 145 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 146 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 176
10.4.1 JAPAN 176
10.4.1.1 Well-developed healthcare system and the rising demand for improvements in the quality of IVD test results to drive market growth in Japan 176
TABLE 147 JAPAN: KEY MACROINDICATORS 176
TABLE 148 JAPAN: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 177
TABLE 149 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 150 JAPAN: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 177
TABLE 151 JAPAN: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 178
TABLE 152 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 153 JAPAN: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 178
10.4.2 CHINA 179
10.4.2.1 Growing access to modern healthcare and government support to boost the market growth in China 179
TABLE 154 CHINA: KEY MACROINDICATORS 179
TABLE 155 CHINA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 180
TABLE 156 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 157 CHINA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 180
TABLE 158 CHINA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 181
TABLE 159 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 160 CHINA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 181
10.4.3 INDIA 182
10.4.3.1 Rising need to secure NABL accreditations to drive the demand for quality controls in India 182
FIGURE 39 INDIA: INCREASING NUMBER OF LABS WITH NABL ACCREDITATIONS,
2012–2020 182
TABLE 161 INDIA: KEY MACROINDICATORS 183
TABLE 162 INDIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 183
TABLE 163 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 164 INDIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 184
TABLE 165 INDIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 184
TABLE 166 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 167 INDIA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 185
10.4.4 AUSTRALIA 185
10.4.4.1 Growing geriatric population has resulted in initiatives to enhance access to healthcare and improve infrastructure 185
TABLE 168 AUSTRALIA: KEY MACROINDICATORS 186
TABLE 169 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 186
TABLE 170 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 171 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 187
TABLE 172 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 187
TABLE 173 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 174 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 188
10.4.5 SOUTH KOREA 188
10.4.5.1 Rising healthcare expenditure and the growing number of hospitals to drive the growth of the South Korean market 188
TABLE 175 SOUTH KOREA: KEY MACROINDICATORS 188
TABLE 176 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 189
TABLE 177 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 178 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 189
TABLE 179 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 190
TABLE 180 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 181 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 190
10.4.6 REST OF ASIA PACIFIC 191
TABLE 182 ROAPAC: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 191
TABLE 183 ROAPAC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 184 ROAPAC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 192
TABLE 185 ROAPAC: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 192
TABLE 186 ROAPAC: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 187 ROAPAC: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 193
10.5 LATIN AMERICA 193
TABLE 188 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 194
TABLE 189 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 194
TABLE 190 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 191 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 195
TABLE 192 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019–2026 (USD MILLION) 195
TABLE 193 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 194 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 196
10.5.1 BRAZIL 196
10.5.1.1 Brazil dominates the Latin American IVD quality control market 196
TABLE 195 BRAZIL: KEY MACROINDICATORS 197
TABLE 196 BRAZIL: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 197
TABLE 197 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 198 BRAZIL: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 198
TABLE 199 BRAZIL: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 198
TABLE 200 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 201 BRAZIL: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 199
10.5.2 MEXICO 199
10.5.2.1 Mexico is emerging as a prominent medical tourism hub 199
TABLE 202 MEXICO: KEY MACROINDICATORS 200
TABLE 203 MEXICO: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 200
TABLE 204 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 205 MEXICO: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 201
TABLE 206 MEXICO: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 201
TABLE 207 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 208 MEXICO: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 202
 
10.5.3 REST OF LATIN AMERICA 202
TABLE 209 ROLA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 202
TABLE 210 ROLA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 211 ROLA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 203
TABLE 212 ROLA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 203
TABLE 213 ROLA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 214 ROLA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 204
10.6 MIDDLE EAST & AFRICA 204
10.6.1 RISING CANCER INCIDENCE HAS ATTRACTED STAKEHOLDER ATTENTION TO REGIONAL MARKETS IN MEA 204
TABLE 215 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 205
TABLE 216 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 217 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 206
TABLE 218 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET,
BY MANUFACTURER, 2019–2026 (USD MILLION) 206
TABLE 219 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 220 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 207
11 COMPETITIVE LANDSCAPE 208
11.1 OVERVIEW 208
11.2 KEY PLAYER STRATEGIES 209
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 210
FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE IVD QUALITY CONTROL MARKET 210
11.4 MARKET SHARE ANALYSIS 210
FIGURE 41 IVD QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2020 211
11.5 COMPANY EVALUATION QUADRANT 212
11.5.1 STARS 212
11.5.2 EMERGING LEADERS 212
11.5.3 PERVASIVE PLAYERS 213
11.5.4 PARTICIPANTS 213
FIGURE 42 IVD QUALITY CONTROL MARKET: COMPANY EVALUATION QUADRANT (2020) 213
11.6 R&D EXPENDITURE 214
FIGURE 43 IVD QUALITY CONTROL MARKET: R&D EXPENDITURE (IN USD MILLION), 2020 214
 
11.7 COMPANY EVALUATION QUADRANT FOR START-UPS 215
11.7.1 PROGRESSIVE COMPANIES 215
11.7.2 DYNAMIC COMPANIES 215
11.7.3 STARTING BLOCKS 215
11.7.4 RESPONSIVE COMPANIES 215
FIGURE 44 IVD QUALITY CONTROL MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020) 216
11.8 COMPANY PRODUCT FOOTPRINT 217
TABLE 221 PRODUCT PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET 217
FIGURE 45 TECHNOLOGY PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET 218
TABLE 222 MANUFACTURER TYPE PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET 219
TABLE 223 END-USER PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET 220
11.9 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE IVD QUALITY CONTROL MARKET 221
TABLE 224 GEOGRAPHIC REVENUE MIX: IVD QUALITY CONTROL MARKET (2020) 221
11.10 COMPETITIVE SCENARIO 222
11.10.1 PRODUCT LAUNCHES 222
TABLE 225 PRODUCT LAUNCHES 222
11.10.2 DEALS 223
TABLE 226 DEALS 223
11.10.3 OTHER DEVELOPMENTS 224
TABLE 227 OTHER DEVELOPMENTS 224

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127